Free Trial

MBX Biosciences (MBX) Competitors

MBX Biosciences logo
$17.00 +0.87 (+5.39%)
Closing price 10/24/2025 04:00 PM Eastern
Extended Trading
$16.89 -0.11 (-0.65%)
As of 10/24/2025 07:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

MBX vs. RCUS, TLRY, TWST, IMCR, BHVN, ABCL, PAHC, JANX, EWTX, and GPCR

Should you be buying MBX Biosciences stock or one of its competitors? The main competitors of MBX Biosciences include Arcus Biosciences (RCUS), Tilray Brands (TLRY), Twist Bioscience (TWST), Immunocore (IMCR), Biohaven (BHVN), AbCellera Biologics (ABCL), Phibro Animal Health (PAHC), Janux Therapeutics (JANX), Edgewise Therapeutics (EWTX), and Structure Therapeutics (GPCR). These companies are all part of the "pharmaceutical products" industry.

MBX Biosciences vs. Its Competitors

Arcus Biosciences (NYSE:RCUS) and MBX Biosciences (NASDAQ:MBX) are both small-cap pharmaceutical products companies, but which is the superior stock? We will compare the two businesses based on the strength of their profitability, institutional ownership, earnings, risk, dividends, valuation, analyst recommendations and media sentiment.

MBX Biosciences has lower revenue, but higher earnings than Arcus Biosciences. Arcus Biosciences is trading at a lower price-to-earnings ratio than MBX Biosciences, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Arcus Biosciences$262M7.04-$283M-$3.17-5.46
MBX BiosciencesN/AN/A-$61.92M-$4.54-3.74

Arcus Biosciences currently has a consensus price target of $27.22, suggesting a potential upside of 57.16%. MBX Biosciences has a consensus price target of $44.00, suggesting a potential upside of 158.82%. Given MBX Biosciences' stronger consensus rating and higher probable upside, analysts plainly believe MBX Biosciences is more favorable than Arcus Biosciences.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Arcus Biosciences
1 Sell rating(s)
2 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
2.60
MBX Biosciences
1 Sell rating(s)
0 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
2.75

92.9% of Arcus Biosciences shares are held by institutional investors. 9.6% of Arcus Biosciences shares are held by insiders. Comparatively, 52.2% of MBX Biosciences shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

MBX Biosciences has a net margin of 0.00% compared to Arcus Biosciences' net margin of -109.56%. MBX Biosciences' return on equity of -31.33% beat Arcus Biosciences' return on equity.

Company Net Margins Return on Equity Return on Assets
Arcus Biosciences-109.56% -55.96% -25.73%
MBX Biosciences N/A -31.33%-29.96%

In the previous week, MBX Biosciences had 5 more articles in the media than Arcus Biosciences. MarketBeat recorded 12 mentions for MBX Biosciences and 7 mentions for Arcus Biosciences. MBX Biosciences' average media sentiment score of 1.37 beat Arcus Biosciences' score of 0.55 indicating that MBX Biosciences is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Arcus Biosciences
2 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive
MBX Biosciences
6 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

MBX Biosciences beats Arcus Biosciences on 9 of the 13 factors compared between the two stocks.

Get MBX Biosciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for MBX and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding MBX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

MBX vs. The Competition

MetricMBX BiosciencesPharmaceutical Preparations IndustryManufacturing SectorNASDAQ Exchange
Market Cap$541.87M$1.08B$2.56B$10.65B
Dividend YieldN/A4.84%2.50%4.82%
P/E Ratio-3.741.4622.0830.57
Price / SalesN/A30.84106.22176.50
Price / CashN/A17.6343.6761.44
Price / Book2.218.0133.126.61
Net Income-$61.92M-$7.35M$6.87M$277.10M
7 Day Performance28.59%2.49%1.14%2.55%
1 Month Performance-1.90%29.62%1.43%3.77%
1 Year PerformanceN/A-14.24%86.32%33.05%

MBX Biosciences Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
MBX
MBX Biosciences
3.513 of 5 stars
$17.00
+5.4%
$44.00
+158.8%
N/A$541.87MN/A-3.74N/APositive News
Insider Trade
RCUS
Arcus Biosciences
2.7737 of 5 stars
$16.49
-0.7%
$26.78
+62.4%
-2.9%$1.75B$258M-5.20500Analyst Forecast
TLRY
Tilray Brands
3.2326 of 5 stars
$1.56
+1.3%
$2.00
+28.2%
-9.1%$1.75B$210.48M-0.692,842Analyst Forecast
TWST
Twist Bioscience
4.0034 of 5 stars
$28.16
-8.4%
$48.56
+72.4%
-15.2%$1.70B$312.97M-19.42990Analyst Forecast
Gap Up
IMCR
Immunocore
2.6836 of 5 stars
$33.56
+0.1%
$56.89
+69.5%
+1.8%$1.69B$310.20M-83.90320News Coverage
Analyst Forecast
BHVN
Biohaven
3.4181 of 5 stars
$16.00
-2.9%
$48.85
+205.3%
-68.3%$1.69BN/A-2.09239News Coverage
Analyst Forecast
ABCL
AbCellera Biologics
2.2769 of 5 stars
$5.59
-4.3%
$8.00
+43.1%
+109.6%$1.67B$28.83M-10.16500Analyst Forecast
Gap Up
PAHC
Phibro Animal Health
3.8371 of 5 stars
$39.72
+3.0%
$28.40
-28.5%
+80.8%$1.61B$1.30B33.662,475News Coverage
Insider Trade
JANX
Janux Therapeutics
1.9789 of 5 stars
$26.76
-1.6%
$78.31
+192.6%
-53.3%$1.61B$10.59M-14.8730News Coverage
EWTX
Edgewise Therapeutics
3.1913 of 5 stars
$15.06
-1.7%
$38.83
+157.9%
-56.2%$1.59BN/A-9.7260Analyst Forecast
GPCR
Structure Therapeutics
3.3108 of 5 stars
$27.38
-0.7%
$68.67
+150.8%
-29.6%$1.58BN/A-26.08136Positive News

Related Companies and Tools


This page (NASDAQ:MBX) was last updated on 10/25/2025 by MarketBeat.com Staff
From Our Partners